These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
992 related items for PubMed ID: 27718153
21. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma. Lan XW, Zou XB, Xiao Y, Tang J, OuYang PY, Su Z, Xie FY. PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025 [Abstract] [Full Text] [Related]
22. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era. Li PJ, Mo HY, Luo DH, Hu WH, Jin T. Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326 [Abstract] [Full Text] [Related]
27. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study. Wei Z, Zhang Z, Luo J, Li N, Peng X. J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162 [Abstract] [Full Text] [Related]
28. Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis. Zhou X, Wang W, Zhou C, Zhu J, Ding W, Chen M, Chen K, Shi Y, Chen X, Kong FM, Yang H. Radiother Oncol; 2022 May; 170():136-142. PubMed ID: 35288229 [Abstract] [Full Text] [Related]
32. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis. Xu C, Sun R, Tang LL, Chen L, Li WF, Mao YP, Zhou GQ, Guo R, Lin AH, Sun Y, Ma J, Hu WH. Oral Oncol; 2018 Mar 01; 78():37-45. PubMed ID: 29496056 [Abstract] [Full Text] [Related]
37. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma. Wang J, Li L, Dong BQ, Xu YJ, Zheng YD, Sun ZW, Yang Y, Chen YY, Chen XZ, Chen M. Oncotarget; 2016 May 10; 7(19):27458-67. PubMed ID: 27050275 [Abstract] [Full Text] [Related]
39. Individualized Concurrent Chemotherapy for Patients with Stage III-IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy. Ji P, Lu Q, Chen X, Chen Y, Peng X, Chen Z, Lin C, Lin S, Zong J. Cancer Res Treat; 2023 Oct 10; 55(4):1113-1122. PubMed ID: 37170497 [Abstract] [Full Text] [Related]
40. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy. Chen YP, Tang LL, Zhang WN, Mao YP, Chen L, Sun Y, Liu LZ, Li WF, Liu X, Zhou GQ, Guo R, Mai HQ, Shao JY, Lin AH, Li L, Ma J. Medicine (Baltimore); 2015 Oct 10; 94(43):e1624. PubMed ID: 26512556 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]